Search

everythinglearnresearchcommunity

for

Search:↓

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

CD34 is a marker for isolating stem-like cells in mouse hair follicles.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Fibroblast spheres can form stem cells, but marker distribution needs more study.

ILC1 cells contribute to hair loss in alopecia areata.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

CD34 marks potential stem cells in dog hair follicles.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

CD44 variant changes start alopecia areata, but don't maintain it.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Targeting specific cell interactions may help treat skin fibrosis.

Telocytes in silky fowl embryos develop distinct features and connections by the 20th day of incubation.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Two main types of fibroblasts with unique functions and additional subtypes were identified in human skin.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Black women with CCCA are more likely to have uterine fibroids.

The research found that different types of fibroblasts are involved in wound healing and that some blood cells can turn into fat cells during this process.